Assignee
PREXTON THERAPEUTICS SA
CH·3 granted patents·2 pending applications·5 citations·filing 2015–2019
Top patents by PatentIndex Score
5 records- 0176US10017521B2Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2015·Granted Jul 10, 2018·3 cites·15 claims
- 0274US10442818B2Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2018·Granted Oct 15, 2019·1 cites·5 claims
- 0366US10532057B2Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesiaPREXTON THERAPEUTICS SA·Filed 2016·Granted Jan 14, 2020·1 cites·20 claims
- 0453US2020171042A1Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesiaPREXTON THERAPEUTICS SA·Filed 2019·Application pending·0 cites
- 0552US2020024285A1Novel chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PREXTON THERAPEUTICS SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →